Cargando…

A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy

OBJECTIVE: To develop and validate a radiomics prognostic scoring system (RPSS) for prediction of progression-free survival (PFS) in patients with stage IV non-small cell lung cancer (NSCLC) treated with platinum-based chemotherapy. METHODS: In this retrospective study, four independent cohorts of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Lan, Li, Zhenhui, Chen, Xin, Huang, Yanqi, Yan, Lixu, Liang, Changhong, Liu, Zaiyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580802/ https://www.ncbi.nlm.nih.gov/pubmed/34815633 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.05.06

Ejemplares similares

Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer
por: He, Lan, et al.
Publicado: (2019)

Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer
por: He, Lan, et al.
Publicado: (2022)

The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
por: Liang, Cuishan, et al.
Publicado: (2016)

Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I−III colorectal cancer
por: Huang, Yanqi, et al.
Publicado: (2022)

Radiomics approach for preoperative identification of stages I−II and III−IV of esophageal cancer
por: Wu, Lei, et al.
Publicado: (2018)

Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule
por: He, Lan, et al.
Publicado: (2016)

Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer
por: Zhao, Ke, et al.
Publicado: (2021)

A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer
por: Xu, Zeyan, et al.
Publicado: (2021)

Computerized tumor-infiltrating lymphocytes density score predicts survival of patients with resectable lung adenocarcinoma
por: Pan, Xipeng, et al.
Publicado: (2022)

Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer
por: Zhao, Ke, et al.
Publicado: (2020)

Hist-Immune signature: a prognostic factor in colorectal cancer using immunohistochemical slide image analysis
por: Zhao, Ke, et al.
Publicado: (2020)

Necrosis score as a prognostic factor in stage I–III colorectal cancer: a retrospective multicenter study
por: Ye, Huifen, et al.
Publicado: (2023)

Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
por: Luo, Yanlin, et al.
Publicado: (2016)

Computed tomography-based radiomics for prediction of neoadjuvant chemotherapy outcomes in locally advanced gastric cancer: A pilot study
por: Li, Zhenhui, et al.
Publicado: (2018)

Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection
por: Li, Pinxiong, et al.
Publicado: (2021)

Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer
por: Jain, Prantesh, et al.
Publicado: (2021)

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy
por: Brady, Anna K., et al.
Publicado: (2015)

Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020)

Microwave ablation combined with chemotherapy improved progression free survival of IV stage lung adenocarcinoma patients compared with chemotherapy alone
por: Li, Chunhai, et al.
Publicado: (2019)

Glasgow Prognostic Score in Patients Receiving Chemotherapy for Non-small-cell Lung Cancer in Stages IIIb and IV
por: Umihanic, Sefika, et al.
Publicado: (2014)

A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer
por: Li, Yexing, et al.
Publicado: (2020)

Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features
por: Zhang, Fang, et al.
Publicado: (2020)

Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection
por: Prieto, Mikel, et al.
Publicado: (2019)

MR diffusion-weighted imaging-based subcutaneous tumour volumetry in a xenografted nude mouse model using 3D Slicer: an accurate and repeatable method
por: Ma, Zelan, et al.
Publicado: (2015)

Treatment of Stage IV Non–Small Cell Lung Cancer with Pembrolizumab in Combination with Platinum-Based Doublet Chemotherapy in Vietnam
por: Nguyen, Khanh Toan, et al.
Publicado: (2023)

CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer
por: Sun, Kai-Yu, et al.
Publicado: (2020)

Intratumoral and Peritumoral Radiomics of Contrast-Enhanced CT for Prediction of Disease-Free Survival and Chemotherapy Response in Stage II/III Gastric Cancer
por: Li, Junmeng, et al.
Publicado: (2020)

Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy
por: Chang, Runsheng, et al.
Publicado: (2023)

Dibromidodimethyldipyridineplatinum(IV)
por: Kelly, Mairéad E., et al.
Publicado: (2008)

Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas
por: Liao, Zhichao, et al.
Publicado: (2022)

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform
por: Lerchbammer-Kreith, Yvonne, et al.
Publicado: (2023)

Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients
por: Zheng, Bo-Hao, et al.
Publicado: (2018)

CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients
por: Bernatz, Simon, et al.
Publicado: (2023)

Platinum(iv) azido complexes undergo copper-free click reactions with alkynes
por: Farrer, Nicola J., et al.
Publicado: (2018)

Malignant Gastrointestinal Neuroectodermal Tumor (GNET) with Prolonged Disease-Free Survival after Platinum-Based Chemotherapy
por: Singh, Daulath, et al.
Publicado: (2020)

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
por: Lee, C K, et al.
Publicado: (2011)

Deep learning quantified mucus-tumor ratio predicting survival of patients with colorectal cancer using whole-slide images
por: Zhao, Ke, et al.
Publicado: (2021)

The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study
por: Liang, Yanting, et al.
Publicado: (2021)

Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy
por: Jin, Hailong, et al.
Publicado: (2013)

Evaluation of human epidermal growth factor receptor 2 status of breast cancer using preoperative multidetector computed tomography with deep learning and handcrafted radiomics features
por: Yang, Xiaojun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6cnvg79vj6uctpuej0pb4bulc8